SynthesisJournal of hepato-biliary-pancreatic sciences2026
Clinical Utility of EUS-FNA/FNB for Diagnosis and Grade Assessment in Pancreatic Neuroendocrine Tumors < 20 mm: A Systematic Review and Meta-Analysis.
Synthesis in Journal of hepato-biliary-pancreatic sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveManagement of pancreatic neuroendocrine tumors (pNETs) < 20 mm remains controversial. Endoscopic ultrasound-guided tissue acquisition is crucial for diagnosis and grading, but data on small pNETs and Ki-67 sample adequacy are limited. This systematic review and meta-analysis evaluated sample adequacy, diagnostic yield, and histologic concordance with surgical specimens.
methodsA systematic search of MEDLINE, EMBASE, and SCOPUS was conducted. Studies reporting diagnostic yield or concordance between EUS-guided fine-needle aspiration (FNA) or biopsy (FNB) and surgical histology in pNETs < 20 mm were included. The primary outcomes were diagnostic yield, concordance with surgical histology, and adequacy of samples for Ki-67-based tumor grading. Pooled estimates were calculated using random-effects models.
results27 studies were included: 17 reported sample adequacy, 9 diagnostic yield, 13 grade concordance, and 5 both yield and grading. Pooled diagnostic yield was 84.4% (95% CI: 0.80-0.87) and pooled concordance rate was 84.2% (95% CI: 0.803-0.882). For sample adequacy to establish tumor grade, the pooled rate was 71.6%. Notably, EUS-FNB demonstrated significantly higher adequacy (79.8%) compared to FNA (52.5%).
conclusionEUS-guided tissue acquisition offers high diagnostic accuracy and reliable tumor grading in pNETs < 20 mm. FNB outperforms FNA in obtaining adequate tissue for grading, underscoring its importance in clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.